Nuveen LLC purchased a new stake in shares of Envista Holdings Corporation (NYSE:NVST - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 309,788 shares of the company's stock, valued at approximately $5,347,000. Nuveen LLC owned about 0.18% of Envista at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Aigen Investment Management LP acquired a new position in Envista in the first quarter valued at about $274,000. Invesco Ltd. lifted its position in Envista by 2.9% in the first quarter. Invesco Ltd. now owns 353,089 shares of the company's stock valued at $6,094,000 after buying an additional 9,950 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Envista by 2.5% in the first quarter. Charles Schwab Investment Management Inc. now owns 2,375,109 shares of the company's stock valued at $40,994,000 after buying an additional 57,478 shares during the last quarter. New Age Alpha Advisors LLC lifted its position in Envista by 7.1% in the first quarter. New Age Alpha Advisors LLC now owns 24,842 shares of the company's stock valued at $429,000 after buying an additional 1,655 shares during the last quarter. Finally, US Bancorp DE lifted its position in Envista by 22.7% in the first quarter. US Bancorp DE now owns 26,898 shares of the company's stock valued at $464,000 after buying an additional 4,979 shares during the last quarter.
Analyst Ratings Changes
NVST has been the topic of several research reports. UBS Group increased their price target on shares of Envista from $18.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 29th. Robert W. Baird raised shares of Envista from a "neutral" rating to an "outperform" rating and increased their price target for the stock from $21.00 to $23.00 in a research report on Tuesday, May 27th. Wall Street Zen cut shares of Envista from a "strong-buy" rating to a "buy" rating in a research report on Saturday. Evercore ISI increased their price target on shares of Envista from $19.00 to $23.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 9th. Finally, Morgan Stanley increased their price target on shares of Envista from $16.00 to $17.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $20.92.
Check Out Our Latest Stock Analysis on Envista
Envista Stock Down 0.5%
Envista stock traded down $0.11 during mid-day trading on Friday, hitting $21.15. The company had a trading volume of 1,038,714 shares, compared to its average volume of 2,144,046. The stock has a market cap of $3.51 billion, a price-to-earnings ratio of 66.08, a PEG ratio of 1.13 and a beta of 1.00. Envista Holdings Corporation has a 1 year low of $14.22 and a 1 year high of $23.00. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46. The business has a fifty day moving average of $20.29 and a 200 day moving average of $18.60.
Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.24 by $0.02. The company had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. The firm's revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.11 earnings per share. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. On average, sell-side analysts expect that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.
About Envista
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories

Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.